Stability of T-cell lineages in autoimmune diseases

Expert Review of Clinical Immunology

Volumn 8, Issue 4, 2012, Pages 299-301

  Raphael, Itay ^a   Forsthuber, Thomas G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

autoimmunity; cytokine; T cell lineage; T cell pathogenicity; T cell plasticity

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CELL LINEAGE; CELL VIABILITY; CYTOKINE PRODUCTION; GASTRITIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; MULTIPLE SCLEROSIS; NOTE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

AUTOIMMUNE DISEASES; CELL LINEAGE; HUMANS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 84861401288     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.22     Document Type: Note

References (32)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357 (1986).
2. Forsthuber TG, Ji N. Quo vadis Th1 and Th2 cells in autoimmunity and infectious diseases: Th17 cells, the new kid on the block. Expert Rev. Clin. Immunol. 3(3), 251-254 (2007).
3. Veldhoen M. The role of T helper subsets in autoimmunity and allergy. Curr. Opin. Immunol. 21, 606-611 (2009).
4. Olsson T. Cytokines in neuroinflammatory disease: Role of myelin autoreactive T cell production of interferon-g. J. Neuroimmunol. 40, 211-218 (1992).
5. Lafaille JJ, Keere FV, Hsu AL et al. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186, 307-312 (1997).
6. Stummvoll GH, DiPaolo RJ, Huter EN et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 181, 1908-1916 (2008).
7. Boursalian TE, Bottomly K. Stability of naive and memory phenotypes on resting CD4 T cells in vivo. J. Immunol. 162, 9-16 (1999).
8. Nakamura T, Lee RK, Nam SY, Podack ER, Bottomly K, Flavell RA. Roles of IL-4 and IFN-g in stabilizing the T helper cell type 1 and 2 phenotype. J. Immunol. 158, 2648-2653 (1997).
9. Sornasse T, Larenas PV, Davis KA, De Vries JE, Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD. J. Exp. Med. 184, 473-483 (1996).
10. Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
11. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
12. Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD. Nat. Immunol. 6, 1123-1132 (2005).
13. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(h)17 cells. Nature 453, 1051-1057 (2008).
14. Chu CQ, Wittmer S, Dalton DK. Failure to suppress the expansion of the activated CD4 T cell population in interferon g-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123-128 (2000).
15. Haak S, Croxford AL, Kreymborg K et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61-69 (2009).
16. Kreymborg K, Etzensperger R, Dumoutier L et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104 (2007).
17. Codarri L, Gyulveszi G, Tosevski V et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560-567 (2011).
18. McQualter JL, Darwiche R, Ewing C et al. Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882 (2001).
19. El-Behi M, Ciric B, Dai H et al. The encephalitogenicity of T(h)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568-575 (2011).
20. Zhou L, Chong MM, Littman DR. Plasticity of CD. Immunity.
21. Bending D, De la Pena H, Veldhoen M et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119, 565-572 (2009).
22. Hirota K, Duarte JH, Veldhoen M et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263 (2011).
23. Quintana FJ, Basso AS, Iglesias AH et al. Control of T(reg) and T(h)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008).
24. Shevach EM. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
25. Bettini ML, Vignali DA. Development of thymically derived natural regulatory T cells. Ann. N.Y. Acad. Sci. 1183, 1-12 (2010).
26. Zhou X, Bailey-Bucktrout SL, Jeker LT et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 (2009).
27. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602 (2009).
28. Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat. Med. 17, 673-675 (2011).
29. Veldhoen M, Uyttenhove C, van Snick J et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
30. Coffman RL, Mocci S, O'Garra A. The stability and reversibility of Th1 and Th2 populations. Curr. Top. Microbiol. Immunol. 238, 1-12 (1999).
31. Perez VL, Lederer JA, Lichtman AH, Abbas AK. Stability of Th1 and Th2 populations. Int. Immunol. 7, 869-875 (1995).
32. Huss DJ, Winger RC, Cox GM et al. TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur. J. Immunol. 41, 2987-2996 (2011).